BlackRock Fund Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$453M Buy
5,661,666
+233,798
+4% +$18.6M 0.08% 231
2016
Q3
$433M Buy
5,427,868
+150,632
+3% +$12.2M 0.09% 222
2016
Q2
$412M Buy
5,277,236
+125,869
+2% +$8.98M 0.09% 212
2016
Q1
$283M Buy
5,151,367
+65,443
+1% +$3.57M 0.07% 326
2015
Q4
$314M Buy
5,085,924
+286,983
+6% +$18.1M 0.07% 282
2015
Q3
$303M Buy
4,798,941
+76,619
+2% +$5.47M 0.08% 258
2015
Q2
$345M Buy
4,722,322
+9,251
+0.2% +$668K 0.08% 229
2015
Q1
$308M Buy
4,713,071
+34,314
+0.7% +$2.28M 0.07% 286
2014
Q4
$304M Buy
4,678,757
+200,076
+4% +$12.9M 0.08% 274
2014
Q3
$269M Buy
4,478,681
+182,711
+4% +$11.9M 0.08% 261
2014
Q2
$297M Sell
4,295,970
-61,830
-1% -$4.01M 0.08% 234
2014
Q1
$285M Buy
4,357,800
+255,251
+6% +$16.6M 0.08% 221
2013
Q4
$254M Buy
4,102,549
+118,304
+3% +$6.85M 0.08% 258
2013
Q3
$214M Buy
3,984,245
+126,383
+3% +$6.51M 0.07% 290
2013
Q2
$176M Buy
+3,857,862
New +$167M 0.06% 339

Other funds holding STJ

BlackRock Fund Advisors's STJ Position: Q4 2016 in Review

BlackRock Fund Advisors increased its St Jude Medical (STJ) stake by 4.3% in Q4 2016, buying an estimated $18.6M and bringing the position to 5,661,666 shares worth $453M. The position accounts for 0.08% of the portfolio, ranked #231.

BlackRock Fund Advisors first reported a position in STJ in Q2 2013 and has held it in 15 quarters since. 550 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • BlackRock Fund Advisors held 5,661,666 shares of St Jude Medical worth $453M as of Q4 2016.
  • BlackRock Fund Advisors bought 233,798 St Jude Medical shares in Q4 2016, an estimated $18.6M.
  • St Jude Medical made up 0.08% of BlackRock Fund Advisors's portfolio in Q4 2016, its #231 holding.
  • BlackRock Fund Advisors first reported a position in St Jude Medical in Q2 2013 and has held it in 15 quarters since.
  • 550 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.